Head-to-Head Comparison
Mounjaro vs Ozempic: Which Weight Loss Injection is Best for You?
A comprehensive UK comparison of Mounjaro (tirzepatide) and Ozempic (semaglutide)—the two most talked-about weight loss injections. Discover which delivers better results, costs less, and might be right for you.
Mounjaro
Tirzepatide
Dual GLP-1/GIP agonist
Ozempic
Semaglutide
GLP-1 agonist
Overview of Mounjaro and Ozempic
Both Mounjaro and Ozempic have taken the UK weight loss world by storm. Originally developed for type 2 diabetes, these injectable medications have proven remarkably effective for obesity treatment—so much so that demand often outstrips supply.
But whilst they're frequently mentioned in the same breath, they're not identical. Mounjaro is the newer medication, approved in the UK in 2022 for diabetes and rolling out for obesity in 2024-2025. Ozempic has been available since 2018 and has a longer track record.
So which should you choose if you're considering a weight loss injection? Let's break down the key differences.
How They Work – Dual vs Single Hormone
The fundamental difference between these medications lies in their mechanism of action:
Mounjaro: Dual Agonist
Targets two hormones:
- GLP-1: Reduces appetite, slows stomach emptying, improves insulin release
- GIP: Enhances insulin sensitivity, may improve fat metabolism
Result: More comprehensive metabolic effects, potentially greater weight loss
Ozempic: Single Agonist
Targets one hormone:
- GLP-1 only: Reduces appetite, slows digestion, helps regulate blood sugar
Result: Proven, powerful appetite suppression with strong safety record
Think of it this way: Ozempic presses one very effective button in your body's weight control system. Mounjaro presses that same button plus an additional one, creating a synergistic effect.
💡 Scientific insight: In head-to-head clinical trials (SURPASS-2), Mounjaro directly outperformed Ozempic for both weight loss and HbA1c reduction in people with type 2 diabetes. Those on Mounjaro 15mg lost an average of 11.2kg vs 6.7kg on Ozempic 1mg over 40 weeks.
Weight Loss Results Comparison
Let's look at what the clinical evidence tells us about real-world results:
Average Weight Loss Over 72 Weeks
Based on clinical trial data. Individual results vary.
What This Means in Real Numbers
Let's translate these percentages into kilos for someone starting at 100kg (about 15st 10lb):
- Mounjaro 15mg: Average loss of 22.5kg (3st 7lb) → Final weight ~77.5kg
- Mounjaro 10mg: Average loss of 19.5kg (3st 1lb) → Final weight ~80.5kg
- Ozempic 2mg: Average loss of 14kg (2st 3lb) → Final weight ~86kg
- Ozempic 1mg: Average loss of 11.5kg (1st 11lb) → Final weight ~88.5kg
The difference is substantial—particularly at higher doses. However, it's crucial to remember these are averages. Some people lose more, some less, depending on adherence, starting weight, diet, exercise, and individual biology.
Side Effects and Tolerability
Both medications share a similar side effect profile because they work on the GLP-1 system. The most common issues are gastrointestinal:
| Side Effect | Mounjaro | Ozempic |
|---|---|---|
| Nausea | 20-30% report (dose-dependent) | 15-25% report |
| Vomiting | 8-12% | 6-10% |
| Diarrhoea | 12-18% | 10-15% |
| Constipation | 10-15% | 8-12% |
| Reduced appetite | Very common (intended effect) | Very common (intended effect) |
| Injection site reactions | Rare | Rare |
| Severity | Usually mild-moderate, improves over time | Usually mild-moderate, improves over time |
Key Differences in Side Effects
- Mounjaro's dual mechanism may cause slightly more nausea initially in some users, though clinical trials show similar rates overall
- GIP activation (unique to Mounjaro) theoretically might reduce nausea compared to GLP-1 alone, but real-world experiences vary
- Both require dose escalation to minimise side effects—starting low and gradually increasing over weeks or months
- Most side effects peak in the first 4-8 weeks then significantly improve as your body adapts
⚠️ Serious (rare) side effects for both: Pancreatitis, gallbladder problems, kidney issues, allergic reactions, and theoretical thyroid tumour risk (seen in animals, not confirmed in humans). Both are contraindicated if you have a personal or family history of medullary thyroid cancer or MEN2 syndrome.
Dosing and Convenience
| Factor | Mounjaro | Ozempic |
|---|---|---|
| Injection frequency | Once weekly | Once weekly |
| Starting dose | 2.5mg (4 weeks) | 0.25mg (4 weeks) |
| Escalation schedule | 2.5mg → 5mg → 7.5mg → 10mg → 12.5mg → 15mg (monthly increases) | 0.25mg → 0.5mg → 1mg → 2mg (monthly increases) |
| Maximum dose | 15mg weekly | 2mg weekly (1mg for diabetes) |
| Pen device | Single-use, pre-filled pen | Multi-dose pen (4 doses per pen) |
| Ease of use | Very easy (hidden needle, auto-inject) | Very easy (dial-a-dose pen) |
Both are extremely convenient compared to daily medications. The injection process takes less than a minute once you're familiar with it. Neither has a clear advantage in terms of ease of use—both pens are well-designed and intuitive.
Cost and Availability in the UK
NHS Access
Both medications have limited NHS availability as of early 2025:
- For Type 2 Diabetes:
- Ozempic: Available on NHS for diabetes since 2018. More established, easier to get prescribed if you meet criteria
- Mounjaro: Approved for diabetes, but newer—some GPs may default to Ozempic first due to familiarity
- For Obesity (without diabetes):
- Ozempic: Not officially indicated for weight loss (that's Wegovy, same drug). Off-label use common but NHS won't fund
- Mounjaro: NICE-approved for obesity Dec 2024, phased NHS rollout for high-BMI patients with comorbidities. Limited initial access
Private Costs
| Dose | Mounjaro (Monthly) | Ozempic (Monthly) |
|---|---|---|
| Low dose (starter) | £170-£210 | £150-£180 |
| Mid dose | £220-£280 | £180-£220 |
| High dose | £280-£350 | £220-£280 |
| Typical 12-month cost | £2,800-£3,500 | £2,200-£3,000 |
Cost considerations:
- Mounjaro is slightly more expensive at higher doses, but the superior weight loss may justify the cost for many
- Prices vary significantly between providers—always compare (that's what this site is for!)
- Some clinics bundle consultation fees, others charge separately
- Demand often outpaces supply, particularly for Ozempic, leading to shortages and price fluctuations
💰 Compare Live Prices
Find the best deals on Mounjaro and Ozempic from verified UK providers
See Current Prices & ProvidersWhich One Should You Choose?
🏆 The Verdict
Mounjaro typically delivers superior weight loss results, making it the stronger option if weight reduction is your primary goal and you can afford the slightly higher cost. However, Ozempic remains an excellent, proven medication with a longer track record—and if you can access it more easily (e.g., via NHS for diabetes) or at a better price, it's absolutely worth using.
Choose Mounjaro if:
- You want maximum weight loss results
- You haven't tried a GLP-1 medication before
- You're comfortable with a newer medication (slightly less long-term data)
- Cost difference is acceptable to you
- You have both type 2 diabetes and significant obesity
Choose Ozempic if:
- You're already prescribed it for type 2 diabetes on the NHS
- You prefer a medication with a longer safety track record (7+ years on market)
- Cost is a major factor and you find it cheaper
- You've tried Mounjaro but experienced intolerable side effects (individual tolerance varies)
- Your clinic has better supply/availability of Ozempic
Or Consider Both
Many people start with Ozempic (especially if prescribed for diabetes) and later switch to Mounjaro if they want to enhance results. Conversely, someone might start with Mounjaro but switch to Ozempic if side effects are challenging or if their GP offers NHS-funded Ozempic for diabetes.
💊 Switching between them: If you've been on Ozempic and want to try Mounjaro (or vice versa), your doctor will guide the transition. Typically there's a dose equivalence consideration—e.g., if you're stable on Ozempic 1mg, you might start Mounjaro at 5-7.5mg rather than the lowest starter dose.
Frequently Asked Questions
Mounjaro typically delivers superior weight loss results. Clinical trials show average weight loss of 20-22% with Mounjaro (15mg dose) versus 10-15% with Ozempic (1-2mg) over similar timeframes. However, individual results vary significantly, and both are highly effective medications. Some people respond better to one or the other.
Privately, Mounjaro is slightly more expensive—typically £20-70 more per month depending on dose. Mounjaro ranges from £170-350/month, whilst Ozempic costs £150-280/month. The price gap narrows at lower doses. NHS availability differs: Ozempic is established for diabetes; Mounjaro is newer with limited obesity access in 2025.
Yes, very similar. Both primarily cause gastrointestinal side effects: nausea (20-30%), vomiting (6-12%), diarrhoea (10-18%), and constipation (8-15%). These typically improve after a few weeks. Some users report Mounjaro causes slightly more initial nausea due to its dual mechanism, though clinical trial rates are comparable. Side effect intensity varies person-to-person.
Yes, many people successfully switch. Your doctor will determine the appropriate starting dose of Mounjaro based on your current Ozempic dose and response. For example, if you're on Ozempic 1mg, you might start Mounjaro at 5-7.5mg rather than 2.5mg. There's typically a transition period where side effects may temporarily increase as your body adjusts to the new medication.
Both start working immediately to suppress appetite, but noticeable weight loss takes weeks. Initial results (first 1-2 months) are often similar as both start at low doses. Mounjaro tends to pull ahead after 3-4 months as doses increase and the dual mechanism has greater effect. However, "faster" doesn't always mean better—gradual, sustainable loss reduces loose skin and maintains muscle mass better.
Both have similar safety profiles and carry the same warnings (pancreatitis risk, thyroid tumour precaution, etc.). Ozempic has more long-term data (7+ years on market vs 3 for Mounjaro), which some people prefer. However, Mounjaro's clinical trials were extensive, and no red flags have emerged. Both are considered safe for most people when properly prescribed and monitored.
Limited access for both. Ozempic is not officially indicated for weight loss (Wegovy is the weight-loss version of semaglutide), so NHS won't fund it for obesity. Mounjaro received NICE approval for obesity in December 2025, with phased NHS rollout starting 2025—but initially only for those with BMI ≥35 with comorbidities or BMI ≥40. Most people seeking these for weight loss currently use private providers.
The Bottom Line
Both Mounjaro and Ozempic are game-changing medications for weight loss. They represent the most effective pharmaceutical treatments for obesity available in 2025—rivalling even bariatric surgery for some patients.
Mounjaro has the edge when it comes to pure weight loss efficacy, thanks to its innovative dual-hormone mechanism. If your primary goal is losing the maximum amount of weight, and you can access and afford it, Mounjaro is the stronger choice.
Ozempic remains excellent, with a proven track record, slightly better affordability, and wider NHS availability for diabetes. It's still significantly more effective than older weight-loss drugs, and millions have had success with it.
Ultimately, the "best" choice depends on your individual circumstances—medical history, budget, availability, and how your body responds. The good news? You're not locked in forever. You can try one, assess results, and switch if needed with your doctor's guidance.
Whichever you choose, combining it with nutritious eating, regular movement, and support will maximise your results and help maintain your weight loss long-term.
Ready to Get Started?
Compare trusted UK providers offering both Mounjaro and Ozempic. Find the best prices and start your weight loss journey today.
Compare Mounjaro & Ozempic Providers⚠️ Medical Disclaimer: This article is for educational and informational purposes only and does not constitute medical advice. Mounjaro and Ozempic are prescription-only medications in the UK. Always consult with a qualified healthcare professional before starting, stopping, or changing any weight loss treatment. Individual results vary. This content has not been evaluated by the MHRA.
Recent News About Related Topics
This guide is regularly reviewed. Here's what's changed recently in the UK: